SUMMARY

InMed AI, also known as InMed Prognostics, is a pioneering company in the field of AI-driven predictive analytics, focusing on multi-modal data including text, signal, and image. A significant achievement of InMed AI is the development of NeuroShield™, the world's only US FDA 510 K approved AI-powered MR volumetric solution. This tool is noteworthy for its ability to provide reference ranges adjusted to age, gender, and ethnicity, thereby contributing to precision medicine. The company's mission revolves around making healthcare tools that are affordable, accessible, reliable, and state-of-the-art, available to everyone globally. This mission is driven by a commitment to address the needs of traditionally underserved and underrepresented populations in both the global north and south markets. InMed AI's focus is on extending the quality of life through technology, and it has a particular emphasis on inclusion and ethnicity in healthcare. NeuroShield™ plays a critical role in the early detection of atrophy in patients suffering from neurodegenerative disorders, which is crucial for the effective use of newly developed pharmaceuticals. InMed AI's expertise also extends to building and deploying tools for remote site monitoring and medical imaging data visualization, applicable in various clinical and research settings. They are actively expanding their product suites to include applications in CT Brain, Whole Body MRI/Video Wellness/Athletic solutions, and lesion solutions for pancreatic and liver cancer.

PRODUCTS

NeuroShield, NeuroFlo, VivoShield Sports

SERVICES

Whole Body Analysis, Body Mass Analysis, Tissue Type Distribution Analysis, Targeted Body Part Analysis, Brain Assessment, Digital Physical Exams and Health Assessments

FOUNDER DETAILS

ABOUT

In-Med Prognostics, founded by Dr. Latha Poonamallee, Dr. Al Curran, and Rajesh Purshottam, stands at the forefront of inclusive AI-driven healthcare innovation. Their mission is to deliver affordable, accessible, reliable, and state-of-the-art healthcare tools universally.

COMPANY TYPE

SERVICE VERTICALS

• Medical Diagnostics

TECHNOLOGY

• Cloud
• Software
• Analytics
• Machine Learning / Deep Learning

THERAPEUTIC AREAS

• Neurology

VALUE OFFERING

• Research
• Diagnosis
• Prevention
• Treatment
• Clinical Workflow
• Non-Clinical Workflow

LOCATION

300, NCL Innovation Park, Dr. Homi Bhabha Road, NCL Colony, Pashan, Pune, Maharashtra, India - 411028

TARGET USERS

• HCP (Healthcare Professionals)
• Corporate

INCORPORATION DATE

10 January 2018

STATE/CITY

Pune, Maharashtra